Literature DB >> 526428

Cell-cycle distribution of urothelial tumour cells as measured by flow cytometry.

L G Collste, Z Darzynkiewicz, F Traganos, T K Sharpless, M Devonec, M L Claps, W F Whitmore, M R Melamed.   

Abstract

The fraction of cells in S + G2 + mitosis from 54 urothelial tumours was calculated by flow cytometry after acridine orange (AO) staining of cells obtained by bladder irrigation or biopsy. Fluorescence signals emitted by the AO-stained DNA and RNA of each cell were separated optically and measured for 5,000 cells per specimen. The patients were classified by the histology of their tumours and clinical data into 5 diagnostic categories: NED (no evidence of disease, but history of bladder tumour), 3; papilloma, 8; non-invasive papillary carcinoma, 8; carcinoma in situ, 17 and invasive carcinoma, 18. The fraction of cells with DNA values in S + G2 + M of the cell cycle varied between 7 and 57% of the total, with a wide range within each diagnostic category, but no statistically significant differences between the groups. The proportion of cells in S + G2 + M from an individual tumour was not correlated with histologic grade or clinical behaviour. The possibility that some tumour cells with DNA values above G1 level are quiescent cells arrested at S or G2 is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526428      PMCID: PMC2010151          DOI: 10.1038/bjc.1979.279

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Flow cytofluorimetry: discrimination between single cells and cell aggregates by direct size measurements.

Authors:  T Sharpless; F Traganos; Z Darzynkiewicz; M R Melamed
Journal:  Acta Cytol       Date:  1975 Nov-Dec       Impact factor: 2.319

2.  EXPERIMENTAL STUDIES ON THE BIOLOGICAL POTENTIAL OF BLADDER TUMORS.

Authors:  R J VEENEMA; B FINGERHUT; J K LATTIMER
Journal:  J Urol       Date:  1965-02       Impact factor: 7.450

3.  ELECTRON MICROSCOPY AND TRITIATED THYMIDINE IN GRADATION OF MALIGNANCY OF HUMAN BLADDER CARCINOMAS.

Authors:  H A BATTIFORA; R EISENSTEIN; H H SKY-PECK; J H MCDONALD
Journal:  J Urol       Date:  1965-02       Impact factor: 7.450

4.  Chromosome markers and progression in bladder cancer.

Authors:  A A Sandberg
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

5.  Analyses of DNA content, nuclear size and cell proliferation of transitional cell carcinoma in man.

Authors:  P E Levi; E H Cooper; C K Anderson; R E Williams
Journal:  Cancer       Date:  1969-05       Impact factor: 6.860

6.  Different sensitivity of chromatin to acid denaturation in quiescent and cycling cells as revealed by flow cytometry.

Authors:  Z Darzynkiewicz; F Traganos; M Andreeff; T Sharpless; M R Melamed
Journal:  J Histochem Cytochem       Date:  1979-01       Impact factor: 2.479

7.  Macrophage-mediated cytostasis of neoplastic hemopoietic cells: cytofluorometric analysis of the reversible cell cycle block.

Authors:  J I Kurland; F Traganos; Z Darzynkiewicz; M A Moore
Journal:  Cell Immunol       Date:  1978-03-15       Impact factor: 4.868

8.  Prognosis in well differentiated noninvasive carcinoma of the bladder based on chromosomal analysis.

Authors:  W H Falor; R M Ward
Journal:  Surg Gynecol Obstet       Date:  1977-04

9.  Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system.

Authors:  F Traganos; Z Darzynkiewicz; T Sharpless; M R Melamed
Journal:  J Histochem Cytochem       Date:  1977-01       Impact factor: 2.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.